Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty

BackgroundTriptorelin, a long-acting gonadotropin-releasing hormone (GnRH) agonist, is available in 1-, 3-, and 6-month formulations to treat central precocious puberty (CPP). The triptorelin pamoate 22.5-mg 6-month formulation recently approved for CPP offers greater convenience to children by redu...

Full description

Bibliographic Details

Published in:	Frontiers in Endocrinology
Main Authors:	Eunjoo Yoo, Sinae Kim, Hye Lim Jung, Jung Yeon Shim, Jae Won Shim, Deok Soo Kim, Ji Hee Kwak, Eun Sil Kim, Aram Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Subjects:	central precocious puberty gonadotrophin-releasing hormone analogue gonadotropins triptorelin pamoate 6-month formulation
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1134977/full